VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
This Quarter Return
+10.19%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$207M
AUM Growth
+$71.8M
Cap. Flow
+$59.1M
Cap. Flow %
28.6%
Top 10 Hldgs %
47.49%
Holding
157
New
10
Increased
64
Reduced
2
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AGEN
76
Agenus
AGEN
$136M
$454K 0.22%
3,220
XNCR icon
77
Xencor
XNCR
$594M
$432K 0.21%
17,649
BLUE
78
DELISTED
bluebird bio
BLUE
$418K 0.2%
476
SAGE
79
DELISTED
Sage Therapeutics
SAGE
$404K 0.2%
8,774
BLCM
80
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$404K 0.2%
2,030
BPMC
81
DELISTED
Blueprint Medicines
BPMC
$387K 0.19%
13,046
RDUS
82
DELISTED
Radius Health, Inc.
RDUS
$378K 0.18%
6,986
SGYP
83
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$376K 0.18%
68,254
BCRX icon
84
BioCryst Pharmaceuticals
BCRX
$1.74B
$374K 0.18%
84,907
LUMO
85
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$367K 0.18%
2,718
NERV icon
86
Minerva Neurosciences
NERV
$16.8M
$362K 0.18%
3,204
INSM icon
87
Insmed
INSM
$30.3B
$356K 0.17%
24,536
LJPC
88
DELISTED
La Jolla Pharmaceutical Company
LJPC
$340K 0.16%
14,291
PRTA icon
89
Prothena Corp
PRTA
$452M
$330K 0.16%
5,509
ADXS
90
DELISTED
Advaxis, Inc.
ADXS
$330K 0.16%
2,059
BWP
91
DELISTED
Boardwalk Pipeline Partners
BWP
$324K 0.16%
+18,873
New +$324K
CEMP
92
DELISTED
Cempra, Inc.
CEMP
$321K 0.16%
13,284
LXRX icon
93
Lexicon Pharmaceuticals
LXRX
$392M
$319K 0.15%
17,649
ARWR icon
94
Arrowhead Research
ARWR
$3.84B
$318K 0.15%
43,272
ONCE
95
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$317K 0.15%
5,281
SRNE
96
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$313K 0.15%
40,438
FGEN icon
97
FibroGen
FGEN
$48.4M
$308K 0.15%
595
FPRX
98
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$306K 0.15%
5,837
FOLD icon
99
Amicus Therapeutics
FOLD
$2.42B
$301K 0.15%
40,705
KPTI icon
100
Karyopharm Therapeutics
KPTI
$61.4M
$298K 0.14%
2,041